February 19, 2018 / 6:03 PM / 9 months ago

BRIEF-Osmotica Pharmaceutical Says FDA Approves OSMOLEX ER For Treatment Of Parkinson’s Disease

Feb 19 (Reuters) - Osmotica Pharmaceutical US LLC:

* FDA APPROVES OSMOTICA PHARMACEUTICAL’S ONCE-DAILY OSMOLEX ER™ (AMANTADINE) EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PARKINSON’S DISEASE AND DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS IN ADULTS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below